GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circa Group AS (OSL:CIRCA) » Definitions » EBITDA Margin %

Circa Group AS (OSL:CIRCA) EBITDA Margin % : -10,212.79% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Circa Group AS EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Circa Group AS's EBITDA for the three months ended in Mar. 2024 was kr-22.37 Mil. Circa Group AS's Revenue for the three months ended in Mar. 2024 was kr0.22 Mil. Therefore, Circa Group AS's EBITDA margin for the quarter that ended in Mar. 2024 was -10,212.79%.


Circa Group AS EBITDA Margin % Historical Data

The historical data trend for Circa Group AS's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Circa Group AS EBITDA Margin % Chart

Circa Group AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
-1,316.09 -36,118.13 -10,076.61 -8,706.49

Circa Group AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,299.76 -175.58 -747.87 172.39 -10,212.79

Competitive Comparison of Circa Group AS's EBITDA Margin %

For the Biotechnology subindustry, Circa Group AS's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Circa Group AS's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Circa Group AS's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Circa Group AS's EBITDA Margin % falls into.



Circa Group AS EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Circa Group AS's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-67.127/0.771
=-8,706.49 %

Circa Group AS's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-22.366/0.219
=-10,212.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Circa Group AS  (OSL:CIRCA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Circa Group AS EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Circa Group AS's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Circa Group AS (OSL:CIRCA) Business Description

Traded in Other Exchanges
Address
Karenslyst alle 53, Oslo, NOR, 0279
Circa Group AS is a biotechnology company. The company is engaged in converting waste biomass into advanced biochemical materials. Its Furacell production process takes abundant waste biomass and makes a platform molecule, levoglucosenone.

Circa Group AS (OSL:CIRCA) Headlines

No Headlines